EASD-Novo Nordisk Foundation Diabetes Prize for Excellence
The EASD-Novo Nordisk Foundation Diabetes Prize for Excellence recognises outstanding achievements in research which has led to significant advances in the understanding, prevention or treatment of diabetes or its complications.
The awardee will receive a personal monetary award accompanied by a monetary award to support the ongoing research of the awardee, generously sponsored by the Novo Nordisk Foundation.The awardee will deliver a Lecture during the EASD Annual Meeting in the year of the award and is expected to provide annual reports on the research supported by the Prize for up to 5 years after receipt of the award.
Call for Nominations - EASD-Novo Nordisk Foundation Diabetes Prize for Excellence 2026
Help us honour excellence in the field - give a valued colleague the recognition they truly deserve!
We invite you to nominate your preferred candidate for the 12th EASD-Novo Nordisk Foundation Diabetes Prize for Excellence! This prestigious award recognises outstanding achievements in research which has led to significant advances in the understanding, prevention or treatment of diabetes or its complications.
To be eligible for nomination:
- Candidates must be an EASD member
- Candidates can be from any country
- There are no age restrictions
- Board Members of EASD or the Novo Nordisk Foundation are not eligible for nomination
- Only employees of universities, hospitals or other non-profit institutions will be considered
- Candidates should be currently active in diabetes research and continuing their research activity for the following 5 years
Nominations should be made on the available nomination form, and sent as one complete PDF to sarah.schotten@easd.org, containing:
- One Letter of Recommendation of not more than 1,000 words signed by up to three nominators. Additional letters will be disregarded.
- Curriculum vitae of the nominee including a list (without reprints) of ten publications considered to reflect the nominee's most important contributions in the field.
2025 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence Recipient
Mathieu (left), Shulman (middle) & Novo Nordisk Foundation Representative (right)
Prof. Gerald I. Shulman, USA
Targeting mitochondria to treat type 2 diabetes and cardiometabolic disease
EASD-Novo Nordisk Foundation Diabetes Prize for Excellence Awardees:
2025 Vienna
G.I. Shulman (US): Targeting mitochondria to treat type 2 diabetes and cardiometabolic disease
2024 Madrid
J.R. Zierath (SE): Deconvoluting signals and metabolic rhythmicity of insulin- and exercise-action in type 2 diabetes
2023 Hamburg
R. Hovorka (UK): Automated insulin delivery - diabetes tech at its best
2022 Stockholm
A.-G. Ziegler (DE): Starting the clock to type 1 diabetes
2021 Virtual Meeting
J.A. Todd (UK): From HLA-DQ position 57 and back again
2020 Virtual Meeting
J.C. Brüning (DE): Brain insulin action in CNS-dependent control of metabolism
2019 Barcelona
D.J. Drucker (CA): Alimentary antidotes for amelioration of metabolic maladies
2018 Berlin
G.S. Hotamisligil (US): A quarter century of immunometabolism
2017 Lisbon
P.E. Scherer (US): The many secret lives of adipocytes: implications for diabetes
2016 Munich
A. Hattersley (UK): Defining heterogeneity in diabetes to improve clinical care
2015 Stockholm
S. O'Rahilly (UK): Human metabolic disease: lessons from genetics
